Novel 2-substituted benzothiazole derivatives: synthesis, in vitro and in silico evaluations as potential anticancer agents

This is a In Vitro Study study (also classified as: Experimental Study).

January 1, 2025RSC AdvancesOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

Benzothiazole derivatives exhibit significant anticancer activity in various tests, indicating their therapeutic potential.
The study emphasizes the synthesis and evaluation of these compounds, with promising results for future cancer treatments.
In vitro and in silico evaluations formed the basis of the research, revealing meaningful interactions with cancer cells.
The findings imply that further development of benzothiazole derivatives could lead to effective anticancer agents.

We only have this paper's title and publication details.

This research demonstrates in vitro and in silico evaluations of benzothiazole derivatives, suggesting potential anticancer properties.

Benzothiazole–benzylidene hybrids exhibit potent anticancer activity.

No takes yet. Share an insight, caveat, or question.

Azzam et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share